Item 1.01 Entry into a Material Definitive Agreement.
Indenture and Notes
OnApril 20, 2023 ,Enovix Corporation (the "Company") completed its previously announced private offerings (collectively, the "Offerings") of$172.5 million aggregate principal amount of 3.00% Convertible Senior Notes due 2028 (the "Notes"), which includes the exercise in full of the initial purchasers' option to purchase up to an additional$22.5 million principal amount of the Notes, and$10.0 million principal amount of Notes (the "Affiliate Notes") issued to an entity affiliated withThurman John "T.J." Rodgers , the Company's Chairman (the "Affiliated Investor"), in a concurrent private placement. The Notes were issued pursuant to an indenture, datedApril 20, 2023 (the "Indenture"), between the Company andU.S. Bank Trust Company, National Association , as trustee. The Notes are general unsecured obligations of the Company and will mature onMay 1, 2028 , unless earlier converted, redeemed, or repurchased. Interest on the Notes will accrue at a rate of 3.00% per year fromApril 20, 2023 and will be payable semiannually in arrears onMay 1 andNovember 1 of each year, beginning onNovember 1, 2023 . The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately precedingFebruary 1, 2028 , only under the following conditions: (1) during any fiscal quarter commencing after the fiscal quarter ending onOctober 1, 2023 (and only during such fiscal quarter), if the last reported sale price of the Company's common stock, par value$0.0001 per share (the "Common Stock"), for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the Notes on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period (the "Measurement Period") in which the trading price (as defined in the Indenture) per$1,000 principal amount of the Notes for each trading day of the Measurement Period was less than 98% of the product of the last reported sale price of the Common Stock and the conversion rate for the Notes on each such trading day; (3) if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Notes called (or deemed called) for redemption; or (4) upon the occurrence of specified corporate events as set forth in the Indenture. On or afterFebruary 1, 2028 , until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, in integral multiples of$1,000 principal amount, at the option of the holder regardless of the foregoing conditions. Upon conversion, the Company may satisfy its conversion obligation by paying or delivering, as the case may be, cash, shares of Common Stock or a combination of cash and shares of Common Stock, at the Company's election, in the manner and subject to the terms and conditions provided in the Indenture. The conversion rate for the Notes will initially be 64.0800 shares of Common Stock per$1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately$15.61 per share of Common Stock. The initial conversion price of the Notes represents a premium of approximately 15% above the last reported sale price of the Common Stock on The Nasdaq Global Select Market onApril 17, 2023 . The conversion rate for the Notes is subject to adjustment in some events in accordance with the terms of the Indenture but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date of the Notes or if the Company delivers a notice of redemption in respect of the Notes, the Company will, under certain circumstances, increase the conversion rate of the Notes for a holder who elects to convert its Notes in connection with such a corporate event or convert its Notes called (or deemed called) for redemption in connection with such notice of redemption, as the case may be. The Company may not redeem the Notes prior toMay 6, 2026 . The Company may redeem for cash all or any portion of the Notes (subject to certain limitations described in the Indenture), at its option, on or afterMay 6, 2026 , if the "liquidity condition" (as defined in the Indenture) is satisfied and the last reported sale price of the Common Stock has been at least 130% of the conversion price for the Notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. If the Company redeems less than all the outstanding Notes, at least$100.0 million aggregate principal amount of Notes must be outstanding and not subject to redemption as of, and after giving effect to, delivery of the relevant notice of redemption. No sinking fund is provided for the Notes. If the Company undergoes a fundamental change (as defined in the Indenture), then, subject to certain conditions and except as described in the Indenture, holders may require the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the . . .
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.
Item 3.02 Unregistered Sales of
The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.
The Company offered and sold the Notes to the initial purchasers and the Affiliated Investor in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"). The Notes (other than the Affiliate Notes) were resold by the initial purchasers to persons reasonably believed to be qualified institutional buyers pursuant to the exemption from registration provided by Section 4(a)(2) and Rule 144A under the Securities Act. The Company relied on these exemptions from registration based in part on representations made by the initial purchasers in the purchase agreement datedApril 17, 2023 by and among the Company and the representative of the initial purchasers, as amended, and the representations made by the Affiliated Investor in a subscription agreement datedApril 17, 2023 by and among the Company and the Affiliated Investor. The Notes and the shares of Common Stock issuable upon conversion of the Notes, if any, have not been registered under the Securities Act and may not be offered or sold inthe United States absent registration or an applicable exemption from registration requirements. To the extent that any shares of Common Stock are issued upon conversion of the Notes, they will be issued in transactions anticipated to be exempt from registration under the Securities Act by virtue of Section 3(a)(9) thereof because no commission or other remuneration is expected to be paid in connection with conversion of the Notes and any resulting issuance of shares of Common Stock. Initially, a maximum of 12,711,852 shares of the Company's Common Stock may be issued upon conversion of the Notes based on the initial maximum conversion rate of 73.6919 shares of Common Stock per$1,000 principal amount of Notes, which is subject to customary anti-dilution adjustment provisions.
Item 8.01 Other Events.
On
Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements including statements concerning the Offerings of the Notes and the capped call transactions and the anticipated use of proceeds from the Offerings. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "seek," "plan," "project," "target," "looking ahead," "look to," "move into," and similar expressions are intended to identify forward-looking statements. Forward-looking statements represent the Company's current beliefs, estimates and assumptions only as of the date of this Current Report on Form 8-K and information contained in this Current Report on Form 8-K should not be relied upon as representing the Company's estimates as of any subsequent date. These forward-looking statements are subject to risks, uncertainties, and assumptions. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Risks include, but are not limited to market risks, trends and conditions. These risks are not exhaustive. Further information on these and other risks that could affect the Company's results is included in its filings with theSecurities and Exchange Commission ("SEC"), including its Annual Report on Form 10-K for the fiscal year endedJanuary 1, 2023 , and the future reports that it may file from time to time with theSEC . The Company assumes no obligation to, and does not currently intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. --------------------------------------------------------------------------------
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description 4.1 Indenture, dated as ofApril 20, 2023 , by and
between
andU.S. Bank Trust Company , National
Association, as Trustee
4.2 Form of Global Note, representing Enovix
Corporation's 3.00% Convertible
Senior Notes due 2028 (included as Exhibit A to the Indenture filed as Exhibit 4.1) 10.1 Form of Confirmation for Capped Call Transactions 99.1 Press release titled "Enovix Announces
Proposed
Convertible Senior Notes Due 2028", datedApril 17, 2023 104 Cover Page Interactive Data File (embedded
within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source